{"content":"<li class=\"n-box-item date-title\" data-end=\"1515214799\" data-start=\"1515128400\" data-txt=\"Monday, December 23, 2019\">Friday, January  5, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3321520\" data-ts=\"1515195741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321520-cytori-therapeutics-jumps-maxim-sees-takeover-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytori Therapeutics jumps as Maxim sees it as takeover candidate</a></h4><ul>   <li>Nanocap Cytori Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a>) vaulted in the last 15 minutes of the week's trading to a <font color='green'>74% gain</font> after it was floated as a likely acquisition candidate by Maxim.</li>    <li>Analyst Jason Kolbert sees Takeda's (TKPYY) play for Tigenix (NASDAQ:<a href='https://seekingalpha.com/symbol/TIG' title='TiGenix NV  &#40;ADS&#41;'>TIG</a>) as a positive sign for Cytori, since it makes a similar adipose-based product for regenerative medicine.</li>    <li>He has a price target of $5 vs. today's close of $0.47.</li>    <li>Volume was about 7.7M shares today vs. an average of less than 1M. Shares have drawn back slightly postmarket, <font color='red'>-13%</font>.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321520\" data-linked=\"Cytori Therapeutics jumps as Maxim sees it as takeover candidate\" data-tweet=\"$CYTX $PSTV $TAK - Cytori Therapeutics jumps as Maxim sees it as takeover candidate https://seekingalpha.com/news/3321520-cytori-therapeutics-jumps-maxim-sees-takeover-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3321520-cytori-therapeutics-jumps-maxim-sees-takeover-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321518\" data-ts=\"1515192344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321518-register-qualcomm-processors-vulnerable-to-recent-exploits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Register: Qualcomm processors vulnerable to recent exploits</a></h4><ul>   <li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) has confirmed that its processors are affected by recent exploits, according to <i>The Register.</i></li>    <li>\"So kind of @Qualcomm to confirm at 2.30pm PT on a Friday that its processors are affected by Meltdown and Spectre, too,\" the publication just tweeted.</li>    <li>Shares have turned down in aftermarket trading, <font color='red'>-0.7%</font>.</li>    <li>The news comes a day after acknowledgment by Apple that all its devices are subject to the processor exploits. After a couple of days of losses, Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) closed <font color='green'>higher today by 0.7%</font>; and <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> lost ground after a couple of strong days, finishing <font color='red'>2% lower</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321518\" data-linked=\"Register: Qualcomm processors vulnerable to recent exploits\" data-tweet=\"$QCOM $QCOM $INTC - Register: Qualcomm processors vulnerable to recent exploits https://seekingalpha.com/news/3321518-register-qualcomm-processors-vulnerable-to-recent-exploits?source=tweet\" data-url=\"https://seekingalpha.com/news/3321518-register-qualcomm-processors-vulnerable-to-recent-exploits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321517\" data-ts=\"1515191709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321517-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/JT' title='Jianpu Technology Inc.'>JT</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a> <font color='green'>+1.4%</font>. <a href='https://seekingalpha.com/symbol/HPI' title='John Hancock Preferred Income Fund'>HPI</a> <font color='green'>+1.3%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-2.2%</font>. <a href='https://seekingalpha.com/symbol/GPT' title='Gramercy Property Trust, Inc.'>GPT</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/APLP' title='Archrock Partners, L.P.'>APLP</a> <font color='red'>-1.2%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color='red'>-1.2%</font>. <a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a> <font color='red'>-1.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321517\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$JT $AUO $HPI - After Hours Gainers / Losers https://seekingalpha.com/news/3321517-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321517-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321516\" data-ts=\"1515189988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321516-glu-mobile-sells-moscow-studio-for-4_5m-sharesplus-2_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile sells Moscow studio for $4.5M; shares +2.1%</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) has sold its Moscow studio and some of the games it made, for about $4.5M.</li>    <li>Shares are <font color='green'>up 2.1%</font> after hours.</li>     <li>The studio had focused on shooter/action games, including franchises around <i>Contact Killer, Frontline Commando,</i> and <i>Blood &amp; Glory</i> -- all of which will move to the company's studio in Hyderabad, India. Live operations for <i>Deer Hunter 2017</i> will also join <i>Deer Hunter Classic</i> in Hyderabad.</li>    <li>Other games made in Moscow -- <i>Last Day Alive, Heroes of Destiny,</i> and a mobile game/license agreement for an unnamed male celebrity -- are being sold.</li>    <li>Glu is getting about $3M in cash and $1.5M in minimum guaranteed royalty payments. It had originally acquired the Moscow operation in 2008.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321516\" data-linked=\"Glu Mobile sells Moscow studio for $4.5M; shares +2.1%\" data-tweet=\"$GLUU - Glu Mobile sells Moscow studio for $4.5M; shares +2.1% https://seekingalpha.com/news/3321516-glu-mobile-sells-moscow-studio-for-4_5m-sharesplus-2_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3321516-glu-mobile-sells-moscow-studio-for-4_5m-sharesplus-2_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321502\" data-ts=\"1515187467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321502-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a> <font color='green'>+5.9%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='green'>+5.8%</font>. <a href='https://seekingalpha.com/symbol/ILF' title='iShares Latin America 40 ETF'>ILF</a> <font color='green'>+5.6%</font>. <a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='green'>+5.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-5.8%</font>. <a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/IDU' title='iShares U.S. Utilities ETF'>IDU</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard REIT Index ETF'>VNQ</a> <font color='red'>-2.3%</font>. <a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-2.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321502\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$EWZ $REMX $ILF - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3321502-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321502-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321501\" data-ts=\"1515186813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321501-records-fall-nasdaq-up-3_4-in-2018-s-and-p-500-2_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More records fall; Nasdaq up 3.4% in 2018, S&amp;P 500 2.5%</a></h4><ul><li>The stock rally showed zero signs of letting up in the year's first week, with the Dow&nbsp;<font color='green'>up 0.9%</font>, and now setting its sights on 26K. The S&amp;P 500&nbsp;<font color='green'>rose 0.7%</font>&nbsp;and the Nasdaq&nbsp;<font color='green'>0.8%</font>. All three indices closed at new records in all four sessions of 2018.</li><li>For the week, the Dow&nbsp;<font color='green'>gained 1.4%</font>, the S&amp;P 500&nbsp;<font color='green'>2.5%</font>, and the Nasdaq&nbsp;<font color='green'>3.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321501\" data-linked=\"More records fall; Nasdaq up 3.4% in 2018, S&amp;P 500 2.5%\" data-tweet=\"More records fall; Nasdaq up 3.4% in 2018, S&amp;P 500 2.5% https://seekingalpha.com/news/3321501-records-fall-nasdaq-up-3_4-in-2018-s-and-p-500-2_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3321501-records-fall-nasdaq-up-3_4-in-2018-s-and-p-500-2_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321500\" data-ts=\"1515186685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321500-form-holdings-becoming-xpresspa-group-changing-symbol\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FORM Holdings becoming XpresSpa Group, changing symbol</a></h4><ul>    <li>FORM Holdings (FH) is making its recent business-unit focus more official, announcing it's <a href=\"https://seekingalpha.com/pr/17039374-form-holdings-announces-name-change-xpresspa-group\" target=\"_blank\">changing its corporate name</a> to XpresSpa Group.</li>    <li>The holding company has been pivoting toward a pure-play wellness services company and continues expanding its XpresSpa locations, with several recent airport openings.</li>    <li>It will keep trading on Nasdaq, but under a new symbol: Starting Monday, it will trade as XSPA.</li>    <li>Shares <font color='green'>rose 9.4%</font> today; they're <font color='red'>down 5.3%</font> in immediate postmarket quotes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321500\" data-linked=\"FORM Holdings becoming XpresSpa Group, changing symbol\" data-tweet=\"$XSPA - FORM Holdings becoming XpresSpa Group, changing symbol https://seekingalpha.com/news/3321500-form-holdings-becoming-xpresspa-group-changing-symbol?source=tweet\" data-url=\"https://seekingalpha.com/news/3321500-form-holdings-becoming-xpresspa-group-changing-symbol\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321499\" data-ts=\"1515186271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VUZI\" target=\"_blank\">VUZI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321499-vuzix-closesplus-18_6-on-news-of-alexa-enabled-smart-glasses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vuzix closes +18.6% on news of Alexa-enabled smart glasses</a></h4><ul><li>        Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a>) shares closed today&nbsp;<font color='green'>up 18.6%</font>&nbsp;after the company <a href=\"https://www.cnbc.com/2018/01/05/vuzix-blade-alexa-glasses-to-premiere-at-ces.html\" target=\"_blank\">announced</a> plans to unveil the first Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) Alexa-enabled smart glasses at CES.</li><li>               The glasses will have an initial price of $1K and a &ldquo;prosumer&rdquo; audience of business customers, but the company says the price will eventually come down.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321453-amazon-announces-dev-kit-bring-alexa-wearables\" target=\"_blank\">Amazon announces dev kit to bring Alexa to wearables</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321499\" data-linked=\"Vuzix closes +18.6% on news of Alexa-enabled smart glasses\" data-tweet=\"$VUZI $VUZI $AMZN - Vuzix closes +18.6% on news of Alexa-enabled smart glasses https://seekingalpha.com/news/3321499-vuzix-closesplus-18_6-on-news-of-alexa-enabled-smart-glasses?source=tweet\" data-url=\"https://seekingalpha.com/news/3321499-vuzix-closesplus-18_6-on-news-of-alexa-enabled-smart-glasses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321496\" data-ts=\"1515185754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321496-bitcoins-back-least-for-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin&#39;s back, at least for today</a></h4><ul><li>Bitcoin's kind of been stuck in a rut for the past three weeks while money has flowed into a number of alt coins. That's reversed a bit today though.</li><li>With most of the crypto sector lit up bright red, Bitcoin is&nbsp;<font color='green'>higher by nearly 9%</font>&nbsp;to $16.5K. About the only other cryptos in the green are other mainstream coins Ether, Litecoin, and Bitcoin Cash.</li><li>Ripple is&nbsp;<font color='red'>down 3%</font>&nbsp;today, and&nbsp;<font color='red'>off about 23%</font>&nbsp;from yesterday's high.</li><li><a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>&nbsp;<font color='green'>+6.2%</font></li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/CRCW' title='The Crypto Company'>OTC:CRCW</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3321380-coinbase-coins-added\" target=\"_blank\">Coinbase: No coins being added</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321496\" data-linked=\"Bitcoin&#39;s back, at least for today\" data-tweet=\"$GBTC $GBTC $COIN - Bitcoin&#39;s back, at least for today https://seekingalpha.com/news/3321496-bitcoins-back-least-for-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3321496-bitcoins-back-least-for-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321495\" data-ts=\"1515185691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321495-acorda-up-12-on-potential-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda up 12% on potential sale</a></h4><ul><li>The WSJ <a href=\"https://www.wsj.com/articles/acorda-therapeutics-exploring-a-potential-sale-1515184331\" target=\"_blank\">reports </a>that Acorda Therapeutics (<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='green'>+11.9%</font>) is exploring a potential sale. The company has been facing generic competition for top seller Ampyra (dalfampridine) since the USPTO invalidated several key patents earlier this year. In Q3, the MS med accounted for almost 99% of its Q3 product revenue of $134.4M ($132.6M).</li><li>Last month, the company resubmitted its U.S. marketing application for INBRIJA for the treatment of OFF periods in Parkinson's disease patients.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316892-acorda-refiles-u-s-marketing-application-parkinsons-med-inbrija-shares-5-percent-premarket\" target=\"_blank\">Acorda refiles U.S. marketing application for Parkinson's med Inbrija; shares up 5% premarket</a> (Dec. 7, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321495\" data-linked=\"Acorda up 12% on potential sale\" data-tweet=\"$ACOR - Acorda up 12% on potential sale https://seekingalpha.com/news/3321495-acorda-up-12-on-potential-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3321495-acorda-up-12-on-potential-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321494\" data-ts=\"1515184250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERJ\" target=\"_blank\">ERJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321494-embraer-down-5-on-profit-taking-talks-boeing-advancing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Embraer down 5% on profit-taking, talks with Boeing advancing</a></h4><ul><li>Embraer (<a href='https://seekingalpha.com/symbol/ERJ' title='Embraer S.A.'>ERJ</a> <font color='red'>-4.5%</font>) slips on more than double normal volume on profit-taking after its 35% runup on Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+3.6%</font>) takeover interest. The selloff was stoked by a WSJ <a href=\"https://www.wsj.com/articles/boeing-tries-to-overcome-brazils-resistance-to-embraer-takeover-1515174634?mg=prod/accounts-wsj\" target=\"_blank\">report </a>that the companies have informally agreed to terms valuing the Brazilian firm at $28 per share.</li><li>Boeing is in talks with the company and Brazilian government on ways to assuage the latter's concerns about a transaction considering the former's defense business.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3321494\" data-linked=\"Embraer down 5% on profit-taking, talks with Boeing advancing\" data-tweet=\"$ERJ $ERJ $BA - Embraer down 5% on profit-taking, talks with Boeing advancing https://seekingalpha.com/news/3321494-embraer-down-5-on-profit-taking-talks-boeing-advancing?source=tweet\" data-url=\"https://seekingalpha.com/news/3321494-embraer-down-5-on-profit-taking-talks-boeing-advancing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321493\" data-ts=\"1515183396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WU\" target=\"_blank\">WU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321493-western-union-spikes-off-of-xrp-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Union spikes off of XRP talk</a></h4><ul> <li>Western Union (<a href='https://seekingalpha.com/symbol/WU' title='The Western Union Company'>WU</a> <font color='green'>+3.8%</font>) spikes in late trading off of reports the company is considering adopting a new XRP payment system.</li> <li>XRP is the token used in the Ripple protocol.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321493\" data-linked=\"Western Union spikes off of XRP talk\" data-tweet=\"$WU - Western Union spikes off of XRP talk https://seekingalpha.com/news/3321493-western-union-spikes-off-of-xrp-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3321493-western-union-spikes-off-of-xrp-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321490\" data-ts=\"1515183172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGE\" target=\"_blank\">YGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321490-yingli-riding-high-after-nearminus-40-gain-in-2017-component-output\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yingli riding high after near-40% gain in 2017 component output</a></h4><ul>   <li>Yingli Green Energy (NYSE:<a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a>) is <font color='green'>up 28.2%</font> after saying in a social media post that its 2017 solar component output was up nearly 40%.</li>    <li>Output and sales volume were almost 3 gigawatts, the company says, hitting its annual target.</li>    <li>Shares hit $2.83 today in NYSE trading for the first time since last April.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321490\" data-linked=\"Yingli riding high after near-40% gain in 2017 component output\" data-tweet=\"$YGE - Yingli riding high after near-40% gain in 2017 component output https://seekingalpha.com/news/3321490-yingli-riding-high-after-nearminus-40-gain-in-2017-component-output?source=tweet\" data-url=\"https://seekingalpha.com/news/3321490-yingli-riding-high-after-nearminus-40-gain-in-2017-component-output\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321487\" data-ts=\"1515182129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321487-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+20%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CBB' title='Cincinnati Bell Inc.'>CBB</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321487\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$CNIT-OLD $YGE $DWCH - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3321487-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321487-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321484\" data-ts=\"1515181177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321484-fitbit-invests-6m-in-diabetes-monitoring-startup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit invests $6M in diabetes monitoring startup</a></h4><ul><li>        Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) <a href=\"https://www.theverge.com/2018/1/5/16854400/fitbit-investment-6-million-sano-blood-sugar-glucose-monitoring\" target=\"_blank\">invests</a> $6M in startup Sano, developer of a small patch that tracks blood sugar levels.</li><li>                  Fitbit&rsquo;s investment could hint towards a desire to turn its wearables into medical devices, a path that Apple is pursuing with its Watch.    </li><li>               Fitbit has existing partnerships with wearable devices makers Medtronic and Dexcom that allows its smartwatch wearers to display glucose-monitoring data. &nbsp;&nbsp;</li><li>               Fitbit could use the boost in sales as it sold 3.6M devices in the most recent quarter, which was down from 5.3M in the prior year&rsquo;s period.&nbsp;                  </li><li>               Fitbit shares are&nbsp;<font color='red'>down 1.3%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321418-fitbit-plus-2_5-percent-roth-initiates-buy\" target=\"_blank\">Fitbit +2.5% as Roth initiates at Buy</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321484\" data-linked=\"Fitbit invests $6M in diabetes monitoring startup\" data-tweet=\"$FIT - Fitbit invests $6M in diabetes monitoring startup https://seekingalpha.com/news/3321484-fitbit-invests-6m-in-diabetes-monitoring-startup?source=tweet\" data-url=\"https://seekingalpha.com/news/3321484-fitbit-invests-6m-in-diabetes-monitoring-startup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321482\" data-ts=\"1515179782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELT\" target=\"_blank\">DELT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321482-delta-tech-up-big-on-rumored-blockchain-move-shares-ahead-142\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta Tech up big on rumored blockchain move, shares ahead 142%</a></h4><ul><li>Shrugging off the widespread opinion that all things related to cryptocurrencies and blockchain technology are in a bubble, investors pile into Delta Technology Holdings (<a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+141.9%</font>) on a whopping 151x surge in volume. The stampede was apparently ignited by a <a href=\"http://etradewire.com/?s=delta+technology\" target=\"_blank\">report </a>on the news website eTradeWire that rumors are circulating that the Chinese chemical outfit may jump into blockchain.</li><li>Nano cap Delta normally trades 185K shares a day. Turnover sits at almost 28M less than two years to the close.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3321482\" data-linked=\"Delta Tech up big on rumored blockchain move, shares ahead 142%\" data-tweet=\"$DELT $DELT-OLD - Delta Tech up big on rumored blockchain move, shares ahead 142% https://seekingalpha.com/news/3321482-delta-tech-up-big-on-rumored-blockchain-move-shares-ahead-142?source=tweet\" data-url=\"https://seekingalpha.com/news/3321482-delta-tech-up-big-on-rumored-blockchain-move-shares-ahead-142\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321481\" data-ts=\"1515179195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321481-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+221%</font>. <a href='https://seekingalpha.com/symbol/PKD-OLD' title='Parker Drilling Company'>PKD-OLD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CGA' title='China Green Agriculture, Inc.'>CGA</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321481\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$DELT-OLD $PKD $USAU - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3321481-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321481-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321479\" data-ts=\"1515178846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBMG\" target=\"_blank\">CBMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321479-cellular-bio-continues-rally-shares-up-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellular Bio continues rally, shares up 19%</a></h4><ul><li>Thinly traded micro cap Cellular Biomedicine Group (<a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+18.9%</font>) is up on more than a 5x surge in volume, albeit on turnover of only 205K shares. The stock has rallied almost 70% since it announced the closing of a $14.5M private capital raise on December 28.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320284-cellular-biomedicine-closes-14_5m-private-placement-offering\" target=\"_blank\">Cellular Biomedicine closes $14.5M private placement offering</a> (Dec. 28, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321479\" data-linked=\"Cellular Bio continues rally, shares up 19%\" data-tweet=\"$CBMG - Cellular Bio continues rally, shares up 19% https://seekingalpha.com/news/3321479-cellular-bio-continues-rally-shares-up-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3321479-cellular-bio-continues-rally-shares-up-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321478\" data-ts=\"1515178124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHIO\" target=\"_blank\">PHIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321478-rxi-pharma-to-reverse-split-shares-1-10-on-monday-shares-down-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RXi Pharma to reverse split shares 1:10 on Monday; shares down 13%</a></h4><ul><li>Aimed at regaining Nasdaq's minimum bid price listing requirement, RXi Pharmaceuticals (RXII <font color='red'>-12.5%</font>) will execute a <a href=\"https://seekingalpha.com/pr/17039279-rxi-pharmaceuticals-announces-reverse-stock-split\" target=\"_blank\">1:10 reverse split</a> of its common stock at 12:01 am ET on Monday, January 8. Post-split trading will commence at the open.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321478\" data-linked=\"RXi Pharma to reverse split shares 1:10 on Monday; shares down 13%\" data-tweet=\"$PHIO - RXi Pharma to reverse split shares 1:10 on Monday; shares down 13% https://seekingalpha.com/news/3321478-rxi-pharma-to-reverse-split-shares-1-10-on-monday-shares-down-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3321478-rxi-pharma-to-reverse-split-shares-1-10-on-monday-shares-down-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321476\" data-ts=\"1515177866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321476-lipocine-slumps-10-ahead-of-ad-com-review-for-tlando\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine slumps 10% ahead of Ad Com review for Tlando</a></h4><ul><li>Lipocine (<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color='red'>-10.3%</font>) is down on a 5x surge in volume ahead of next Wednesday's FDA Ad Com review for oral testosterone replacement therapy TLANDO (testosterone undecanoate).</li><li>The day before, the advisory committee plans to discuss Clarus Therapeutics' application for JATENZO (testosterone undecanoate) for the same indication.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321471-ad-com-next-week-clarus-therapeutics-oral-testosterone\" target=\"_blank\">Ad Com next week for Clarus Therapeutics' oral testosterone</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321476\" data-linked=\"Lipocine slumps 10% ahead of Ad Com review for Tlando\" data-tweet=\"$LPCN - Lipocine slumps 10% ahead of Ad Com review for Tlando https://seekingalpha.com/news/3321476-lipocine-slumps-10-ahead-of-ad-com-review-for-tlando?source=tweet\" data-url=\"https://seekingalpha.com/news/3321476-lipocine-slumps-10-ahead-of-ad-com-review-for-tlando\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321473\" data-ts=\"1515176106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321473-financials-top-5-gainers-losers-of-1-15-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:15 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/LND' title='BrasilAgro - Brazilian Agricultural Real Estate Co ADR'>LND</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/HCI' title='HCI Group, Inc.'>HCI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PZN' title='Pzena Investment Management, Inc.'>PZN</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321473\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:15 PM\" data-tweet=\"$IIPR $LND $CCCR-OLD - Financials - Top 5 Gainers / Losers as of 1:15 PM https://seekingalpha.com/news/3321473-financials-top-5-gainers-losers-of-1-15-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321473-financials-top-5-gainers-losers-of-1-15-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321470\" data-ts=\"1515174490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321470-goldman-sachs-calls-nvidia-entegris-top-picks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs calls Nvidia, Entegris top picks</a></h4><ul><li>        Goldman Sachs <a href=\"https://www.cnbc.com/2018/01/05/goldman-says-nvidia-best-chip-stock-last-year-headed-for-another-big-year.html\" target=\"_blank\">reiterates</a> its Buy rating for Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) and expects the company to report earnings that beat expectations.</li><li>               Analyst Toshiya Hari notes that Nvidia is &ldquo;exposed to multiple secular growth markets&rdquo; and sees gaming as a &ldquo;meaningful and sustainable growth driver&rdquo; for the company.&nbsp;</li><li>               Goldman says its top picks in Semis and Semi Cap are Nvidia and Entegris (NASDAQ:<a href='https://seekingalpha.com/symbol/ENTG' title='Entegris, Inc.'>ENTG</a>).&nbsp;</li><li>               Hari expects a new Volta GPU launch in Q2 or Q3 and forecasts FY19 EPS of $6, compared to the $4.53 consensus.&nbsp;</li><li>               Price target reaffirmed at $228, a 7% upside on yesterday&rsquo;s closing price.&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='green'>up 0.9%</font>.&nbsp;</li><li>               Entegris shares are&nbsp;<font color='green'>up 0.9%</font>. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321144-western-digital-minus-1_6-percent-analyst-downgrade-price-target-cut\" target=\"_blank\">Western Digital -1.6% on analyst downgrade, price target cut</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321470\" data-linked=\"Goldman Sachs calls Nvidia, Entegris top picks\" data-tweet=\"$NVDA $NVDA $ENTG - Goldman Sachs calls Nvidia, Entegris top picks https://seekingalpha.com/news/3321470-goldman-sachs-calls-nvidia-entegris-top-picks?source=tweet\" data-url=\"https://seekingalpha.com/news/3321470-goldman-sachs-calls-nvidia-entegris-top-picks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321469\" data-ts=\"1515174010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321469-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+224%</font>. <a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a> <font color='green'>+57%</font>. <a href='https://seekingalpha.com/symbol/SKY' title='Skyline Champion Corp'>SKY</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/ORPN' title='Bio Blast Pharma'>ORPN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+17%</font>. APRI <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='red'>-81%</font>. <a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/CORE' title='Core-Mark Holding Company, Inc.'>CORE</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321469\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$DELT-OLD $CNIT-OLD $SKY - Midday Gainers / Losers https://seekingalpha.com/news/3321469-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321469-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321462\" data-ts=\"1515173444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAS\" target=\"_blank\">SEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321462-midday-spike-for-seaworld-entertainment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday spike for SeaWorld Entertainment</a></h4><ul> <li>Shares of SeaWorld Entertainment (<a href='https://seekingalpha.com/symbol/SEAS' title='SeaWorld Entertainment Inc.'>SEAS</a> <font color='green'>+1.8%</font>) jolt awake on a volume spike after sitting in negative territory for most of the day.</li> <li>At the moment there isn't any clear indication what all the excitement is about. The company is due to deliver a presentation next week at the ICR Conference.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321462\" data-linked=\"Midday spike for SeaWorld Entertainment\" data-tweet=\"$SEAS - Midday spike for SeaWorld Entertainment https://seekingalpha.com/news/3321462-midday-spike-for-seaworld-entertainment?source=tweet\" data-url=\"https://seekingalpha.com/news/3321462-midday-spike-for-seaworld-entertainment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321461\" data-ts=\"1515173073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWCH\" target=\"_blank\">DWCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321461-reuters-datawatch-hires-financial-adviser-for-acquisition-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Datawatch hires financial adviser for acquisition interest</a></h4><ul><li>        Datawatch (NASDAQ:<a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a>) shares keep gaining on yesterday&rsquo;s news that the company hired a financial adviser after receiving acquisition interest.</li><li>               <a href=\"https://www.reuters.com/article/us-datawatch-m-a/datawatch-hires-adviser-to-handle-acquisition-approaches-sources-idUSKBN1ET2EO\" target=\"_blank\">Reuters sources</a> say the talks are in early stages and could fail to lead to a deal or result in another outcome like a commercial partnership.&nbsp;</li><li>               Datawatch&rsquo;s FY17 annual revenue rose 19% compared to the previous year to $36.26M and the net loss narrowed to $4M from $14.63M.&nbsp;</li><li>               Datawatch shares are&nbsp;<font color='green'>up 25%</font>. Shares of competitor Alteryx (NYSE:<a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a>) are&nbsp;<font color='green'>up 2.3%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321461\" data-linked=\"Reuters: Datawatch hires financial adviser for acquisition interest\" data-tweet=\"$DWCH $DWCH $AYX - Reuters: Datawatch hires financial adviser for acquisition interest https://seekingalpha.com/news/3321461-reuters-datawatch-hires-financial-adviser-for-acquisition-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3321461-reuters-datawatch-hires-financial-adviser-for-acquisition-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321459\" data-ts=\"1515172174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321459-netflix-bumps-news-of-letterman-show-debut-featuring-obama\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix bumps with news of Letterman show debut featuring Obama</a></h4><ul>   <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is seeing a Letterman tick-up, now <font color='green'>up 1.3%</font>, after <a href=\"https://twitter.com/netflix/status/949319780070187008\" target=\"_blank\">tweeting out</a> that former <i>CBS Late Show</i> veteran David Letterman's new monthly interview show, <i>My Next Guest Needs No Introduction,</i> will debut in a week with an all-star guest lineup.</li>    <li>The Jan. 12 edition will debut with President Barack Obama and include George Clooney, Malala Yousafzai, Tina Fey, Howard Stern and Jay-Z, Netflix says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321459\" data-linked=\"Netflix bumps with news of Letterman show debut featuring Obama\" data-tweet=\"$NFLX - Netflix bumps with news of Letterman show debut featuring Obama https://seekingalpha.com/news/3321459-netflix-bumps-news-of-letterman-show-debut-featuring-obama?source=tweet\" data-url=\"https://seekingalpha.com/news/3321459-netflix-bumps-news-of-letterman-show-debut-featuring-obama\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321455\" data-ts=\"1515171708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321455-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> XNY <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BORN' title='China New Borun Corporation'>BORN</a> <font color='green'>+11%</font>. ONP <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TVPT' title='Travelport'>TVPT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321455\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$DXF $FFHL $BORN - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3321455-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321455-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321458\" data-ts=\"1515171423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKY\" target=\"_blank\">SKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321458-skyline-and-champion-home-builders-announce-agreement-on-business-combination-sharesplus-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skyline and Champion Home Builders announce agreement on business combination; Shares +36%</a></h4><ul>     <li>Skyline Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/SKY' title='Skyline Champion Corp'>SKY</a>) and Champion Enterprises Holdings, LLC, the parent company of Champion Home Builders, Inc. announced that they have entered into a definitive agreement&nbsp;to combine their operations.</li>     <li>The transaction is expected to be completed in the 1H18, (Subject to regulatory, shareholders approval &amp; other customary closing conditions).</li>     <li>Art Decio, Skyline's largest shareholder, has agreed to vote in favor of and fully support the transaction.</li>     <li>Under the terms of the agreement, Champion will contribute 100% of the shares of its operating subsidiaries, Champion Home Builders, Inc. and CHB International B.V., to Skyline. In exchange, Skyline is currently expected to issue ~47.8M shares to Champion, representing 84.5% of the common stock of the combined company on a fully-diluted basis.</li>     <li>Prior to closing, Skyline expects to declare a dividend to its existing shareholders of its excess net cash available for distribution under the agreement after certain transactional expenses.</li>     <li>Skyline expects significantly increased size and scale, with pro forma combined revenue of greater than $1B (past 12 months), Strong pro forma balance sheet and significant cash flow to support continued flexibility and long-term strategic growth  &amp; significant annual synergies post transaction.</li>     <li>The combined company will be known as Skyline Champion Corporation and trade on the NYSE American under the ticker symbol \"SKY.\"</li><li><a href=\"https://seekingalpha.com/pr/17039065-skyline-champion-home-builders-announce-agreement-business-combination-create-nations-largest\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321458\" data-linked=\"Skyline and Champion Home Builders announce agreement on business combination; Shares +36%\" data-tweet=\"$SKY - Skyline and Champion Home Builders announce agreement on business combination; Shares +36% https://seekingalpha.com/news/3321458-skyline-and-champion-home-builders-announce-agreement-on-business-combination-sharesplus-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3321458-skyline-and-champion-home-builders-announce-agreement-on-business-combination-sharesplus-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321453\" data-ts=\"1515170584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321453-amazon-announces-dev-kit-to-bring-alexa-to-wearables\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon announces dev kit to bring Alexa to wearables</a></h4><ul><li>Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>)&nbsp;<a href=\"https://developer.amazon.com/blogs/alexa/post/564685cf-0b1b-4fe4-824e-2ce1e88e3e78/amazon-alexa-mobile-accessories-a-new-alexa-enabled-product-category-with-dev-tools-coming-soon\" target=\"_blank\">announces</a> a new Alexa Mobile Accessory Kit that makes it easier for developers to bring Alexa into smartwatches, headphones, and other wearables.&nbsp;</li><li>               The toolset will launch later this year and is aimed at low-power devices that communicate with the Alexa app in an iOS or Android smartphone, which processes the request.&nbsp;</li><li>               Involved partners include Bose, iHome, and Jabra. &nbsp;&nbsp;&nbsp;</li><li>                  Amazon shares are&nbsp;<font color='green'>up 0.7%</font>.&nbsp;&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3321243-alexa-can-now-control-microwaves-ovens-amazon-invests-smart-oven-startup\" target=\"_blank\">Alexa can now control microwaves, ovens; Amazon invests in smart oven startup</a> (Jan. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321389-amazon-talks-premier-league-streaming-rights\" target=\"_blank\">Amazon in talks for Premier League streaming rights</a> (Jan. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321451-cbs-adds-ad-light-live-streaming-service-amazon-channels\" target=\"_blank\">CBS adds ad-light live streaming service to Amazon Channels</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321453\" data-linked=\"Amazon announces dev kit to bring Alexa to wearables\" data-tweet=\"$AMZN - Amazon announces dev kit to bring Alexa to wearables https://seekingalpha.com/news/3321453-amazon-announces-dev-kit-to-bring-alexa-to-wearables?source=tweet\" data-url=\"https://seekingalpha.com/news/3321453-amazon-announces-dev-kit-to-bring-alexa-to-wearables\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321447\" data-ts=\"1515168336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBCC\" target=\"_blank\">LBCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321447-long-blockchain-gets-busy-new-direction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long Blockchain gets busy with new direction</a></h4><ul>     <li>Long Blockchain Corp. announces that Nasdaq has approved a change of the company's stock trading ticker symbol to <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> from LTEA.</li>     <li>Effective today, Long Blockchain will trade with the new symbol.</li>     <li>The company also disclosed a share offering of 1.6M shares at $5.25. The offering is set to close on January 9.</li>     <li>Also in the works today is a deal signed by Long Blockchain with certain third parties to purchase 1,000 Antminer S9 mining rigs and 1,000 APW3++ PSUs manufactured by Bitmain.</li><li>The mining equipment is expected to be shipped this month directly to a secure data center in the Nordic region to immediately commence mining operations.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17038931-long-blockchain-corp-announces-stock-ticker-symbol-change-lbcc\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321447\" data-linked=\"Long Blockchain gets busy with new direction\" data-tweet=\"$LBCC - Long Blockchain gets busy with new direction https://seekingalpha.com/news/3321447-long-blockchain-gets-busy-new-direction?source=tweet\" data-url=\"https://seekingalpha.com/news/3321447-long-blockchain-gets-busy-new-direction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321446\" data-ts=\"1515168283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNTA\" target=\"_blank\">MNTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321446-momentas-m281-demonstrates-proof-of-mechanism-in-early-stage-study-shares-ahead-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momenta&#39;s M281 demonstrates proof of mechanism in early-stage study; shares ahead 12%</a></h4><ul><li>Momenta Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a> <font color='green'>+11.5%</font>) is up on almost 20% higher volume on the heels of its <a href=\"https://seekingalpha.com/pr/17038965-momenta-pharmaceuticals-reports-positive-top-line-phase-1-data-showing-proof-mechanism-m281\" target=\"_blank\">announcement </a>of positive results from a Phase 1 single-ascending dose study of M281 in healthy volunteers.</li><li>M281 was safe, well-tolerated and demonstrated proof of mechanism by decreasing circulating IgG levels up to 89% (mean reduction was 84%).</li><li>Topline results will be presented at JPM18. Complete data will be presented at an upcoming company event and at a future medical conference.</li><li>A proof-of-concept study will launch in H2 pending regulatory feedback.</li><li>M281 is a fully human anti-neonatal Fc receptor (FcRN) immunoglobulin G (IgG1) designed to reduce circulating pathogenic IgG antibodies in the blood. It works by blocking IgG recycling via FcRN.</li><li>#JPM18</li></ul><div class=\"tiny-share-widget\" data-id=\"3321446\" data-linked=\"Momenta&#39;s M281 demonstrates proof of mechanism in early-stage study; shares ahead 12%\" data-tweet=\"$MNTA - Momenta&#39;s M281 demonstrates proof of mechanism in early-stage study; shares ahead 12% https://seekingalpha.com/news/3321446-momentas-m281-demonstrates-proof-of-mechanism-in-early-stage-study-shares-ahead-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3321446-momentas-m281-demonstrates-proof-of-mechanism-in-early-stage-study-shares-ahead-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321424\" data-ts=\"1515168096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321424-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+17%</font>. APRI <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='red'>-81%</font>. <a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321424\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CBMG $SEEL $ATEC - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3321424-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3321424-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321444\" data-ts=\"1515167803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNNF\" target=\"_blank\">SSNNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321444-trendforce-drops-q1-dram-estimate-after-samsung-china-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TrendForce drops Q1 DRAM estimate after Samsung, China meeting</a></h4><ul><li>        TrendForce&rsquo;s DRAMeXchange <a href=\"http://press.trendforce.com/node/view/3044.html\" target=\"_blank\">narrows</a> its mobile DRAM average sequential increase to 3% in Q1, down from 5%. The cut comes after Samsung (<a href='https://seekingalpha.com/symbol/SSNNF' title='Samsung Electronics Co., Ltd.'>OTC:SSNNF</a>, <a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) met with Chinese authorities concerned about its role in rising memory prices.</li><li>               China&rsquo;s National Development and Reform Commission &#40;NDRC&#41; held the meeting after receiving appeals from domestic smartphone makers feeling pressure from component costs.&nbsp;</li><li>               &ldquo;By petitioning NDRC to investigate Samsung for monopolistic practices, Chinese smartphone brands hope that Samsung and DRAM suppliers following its lead will consider carefully before initiating the next round of price hikes,&rdquo; says DRAMeXchange research analyst Avril Wu.&nbsp;</li><li>               The research firm estimates that average DRAM selling price increased over 40% last year with the average NAND price rising nearly 40% in the same period.&nbsp;</li><li>               Samsung led both NAND and DRAM markets in Q3, accounting for nearly 46% of global DRAM revenue and 37% of global NAND revenue. &nbsp;&nbsp;</li><li>               Shares of major DRAM player Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) are&nbsp;<font color='red'>down 2.3%</font>following the report.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321272-samsung-unveils-new-processor-power-galaxy-s9-copy-apple\" target=\"_blank\">Samsung unveils new processor that could power Galaxy S9 and copy Apple</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321444\" data-linked=\"TrendForce drops Q1 DRAM estimate after Samsung, China meeting\" data-tweet=\"$SSNNF $SSNNF $SSNLF - TrendForce drops Q1 DRAM estimate after Samsung, China meeting https://seekingalpha.com/news/3321444-trendforce-drops-q1-dram-estimate-after-samsung-china-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3321444-trendforce-drops-q1-dram-estimate-after-samsung-china-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321439\" data-ts=\"1515166486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321439-yy-looking-to-fuel-margin-growth-esports-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY looking to fuel margin growth with esports IPO</a></h4><ul>   <li>Plans by YY (<a href=\"http://seekingalpha.com/symbol/YY\" target=\"_blank\">YY</a> <font color='green'>+1.9%</font>) to list its esports platform Huya in the U.S. may provide a hot IPO if <a href=\"https://www.bloomberg.com/gadfly/articles/2018-01-05/gamers-may-beat-dancers-in-yy-s-streaming-spinoff?utm_source=yahoo&amp;utm_medium=bd&amp;utm_campaign=headline&amp;cmpId=yhoo.headline&amp;yptr=yahoo\" target=\"_blank\">financials stay on the same track</a>, Bloomberg's Tim Culpan says.</li>    <li>The unit, similar to live-streaming service Twitch, is looking to raise at least $200M in a U.S. listing.</li>    <li>It's not been making money, but losses have narrowed, he notes (to 14.1M yuan in Q3 from a prior-year loss of 170M yuan), while margin at YY's other key unit -- YY Live -- has been shrinking even amid revenue growth.</li>    <li>That business, which lets amateur tubers sing or teach classes and seek digital gifts from users, is spending more in marketing but seeing diminishing returns as it fights rivals including Momo (<a href=\"http://seekingalpha.com/symbol/MOMO\" target=\"_blank\">MOMO</a> <font color='green'>+1.9%</font>).</li>    <li>The Chinese esports market is expected to generate 3B yuan in revenue (about $462M) and draw 140M users this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321439\" data-linked=\"YY looking to fuel margin growth with esports IPO\" data-tweet=\"$YY $YY $MOMO - YY looking to fuel margin growth with esports IPO https://seekingalpha.com/news/3321439-yy-looking-to-fuel-margin-growth-esports-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3321439-yy-looking-to-fuel-margin-growth-esports-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321437\" data-ts=\"1515165954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321437-buckingham-research-updates-on-nike-and-under-armour\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckingham Research updates on Nike and Under Armour</a></h4><ul> <li>Buckingham Research weighs in on Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+0.8%</font>) and Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a> <font color='green'>+5%</font>) in new notes published today.</li> <li>Nike is initiated with a <a href=\"https://twitter.com/BuckResearch/status/949256957877243904\" target=\"_blank\">Buy rating</a>: \"Innovation Refresh + Accretive Levers = Superior Growth.\"</li> <li>Under Armour UA is <a href=\"https://twitter.com/BuckResearch/status/949256989313560576\" target=\"_blank\">started off</a> at Neutral: \"Operational Execution Key for Turn.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321437\" data-linked=\"Buckingham Research updates on Nike and Under Armour\" data-tweet=\"$NKE $NKE $UAA - Buckingham Research updates on Nike and Under Armour https://seekingalpha.com/news/3321437-buckingham-research-updates-on-nike-and-under-armour?source=tweet\" data-url=\"https://seekingalpha.com/news/3321437-buckingham-research-updates-on-nike-and-under-armour\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321436\" data-ts=\"1515165433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321436-painful-drop-for-barnes-noble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Painful drop for Barnes &amp; Noble</a></h4><ul> <li>Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='red'>-14.2%</font>) falls to a multi-year low after posting disappointing results for the two-month holiday period.</li> <li>Sales from the book business were down 4.5% for the period and total comparable sales fell 6.4%.</li> <li>The well-known bookstore chain now trades with a market cap of around $402M. Though the dividend yield is now over 10%, some investors have questioned if the payout level is sustainable.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321379-barnes-and-noble-updates-holiday-sales\" target=\"_blank\">Barnes &amp; Noble updates on holiday sales</a> (Jan. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321436\" data-linked=\"Painful drop for Barnes &amp; Noble\" data-tweet=\"$BKS - Painful drop for Barnes &amp; Noble https://seekingalpha.com/news/3321436-painful-drop-for-barnes-noble?source=tweet\" data-url=\"https://seekingalpha.com/news/3321436-painful-drop-for-barnes-noble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321435\" data-ts=\"1515165230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOVN\" target=\"_blank\">NOVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321435-novan-prices-stock-offering-3_80-shares-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novan prices stock offering at $3.80; shares down 18%</a></h4><ul><li>Thinly traded nano cap Novan (<a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a> <font color='red'>-18.2%</font>) is down on almost a 5x surge in volume, albeit on turnover of only 224K shares, in response to the <a href=\"https://seekingalpha.com/pr/17039098-novan-announces-pricing-38_0-million-offering-common-stock-warrants\" target=\"_blank\">pricing </a>of its equity offering.</li><li>The company is offering 10M common shares and 10M warrants at a combined price of $3.80. Each<a href=\"https://www.sec.gov/Archives/edgar/data/1467154/000119312518003732/d518986dfwp.htm\" target=\"_blank\"> four-year warrant</a> is exercisable at $4.66 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321435\" data-linked=\"Novan prices stock offering at $3.80; shares down 18%\" data-tweet=\"$NOVN - Novan prices stock offering at $3.80; shares down 18% https://seekingalpha.com/news/3321435-novan-prices-stock-offering-3_80-shares-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3321435-novan-prices-stock-offering-3_80-shares-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321429\" data-ts=\"1515164356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNP\" target=\"_blank\">UNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321429-wall-street-love-for-rails\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More Wall Street love for rails</a></h4><ul> <li>Another strong call on railroad stocks arrives this morning as Wall Street continues to point to upside for 2018 from tax reform benefits, falling capex spending and margin gains.</li> <li>Wolfe Research issues a sector-wide upgrade to Overweight and now has Union Pacific (<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color='green'>+1.5%</font>), CSX (<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='green'>+1.1%</font>) and Norfolk Southern (<a href='https://seekingalpha.com/symbol/NSC' title='Norfolk Southern Corporation'>NSC</a> <font color='green'>+1.4%</font>) all lined up at Outperform.</li> <li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321233-citi-sees-gains-railroad-stocks\" target=\"_blank\">Citi sees more gains for railroad stocks</a> (Jan. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321429\" data-linked=\"More Wall Street love for rails\" data-tweet=\"$UNP $UNP $CSX - More Wall Street love for rails https://seekingalpha.com/news/3321429-wall-street-love-for-rails?source=tweet\" data-url=\"https://seekingalpha.com/news/3321429-wall-street-love-for-rails\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321428\" data-ts=\"1515164214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIPT\" target=\"_blank\">AIPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321428-skyline-medical-prices-equity-offering-0_95-unit-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skyline Medical prices equity offering at $0.95/Unit; shares down 6%</a></h4><ul><li>Skyline Medical (SKLN <font color='red'>-6.1%</font>) <a href=\"https://seekingalpha.com/pr/17039140-skyline-medical-announces-pricing-firm-commitment-public-offering-common-stock-warrants\" target=\"_blank\">prices </a>its public offering of 2.9M Units at $0.95 per Unit.</li><li>Each Unit consists of one share of common stock and 0.3 of a Series E Warrant to purchase one share of common at $1.00.</li><li>Underwriter's over-allotment is an additional 290K shares of stock and/or 87K Series E Warrants. Closing date is January 9.</li><li>Gross proceeds should be $2.755M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321428\" data-linked=\"Skyline Medical prices equity offering at $0.95/Unit; shares down 6%\" data-tweet=\"$AIPT $POAI - Skyline Medical prices equity offering at $0.95/Unit; shares down 6% https://seekingalpha.com/news/3321428-skyline-medical-prices-equity-offering-0_95-unit-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321428-skyline-medical-prices-equity-offering-0_95-unit-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321427\" data-ts=\"1515163663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DYNT\" target=\"_blank\">DYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321427-dynatronics-announces-distribution-agreement-orthopedic-outfitters-sharesplus-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynatronics announces distribution agreement with Orthopedic Outfitters; shares +5%</a></h4><ul>     <li>Dynatronics Corporation (<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='green'>+4.9%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17039113-dynatronics-announces-distribution-agreement-orthopedic-outfitters\" target=\"_blank\">announced</a> a new distribution agreement for the Company's Dynatronics&trade; division's products (including the Dynatron Solaris&reg; Plus, ThermoStim&trade; Probe, and 125B Portable Ultrasound) with Orthopedic Outfitters.</li>     <li>The Orthopedic Outfitters is a leading distributor of physical therapy and rehabilitation products in Northern California.</li>     <li>CEO of Dynatronics,&nbsp;&nbsp;Kelvyn H. Cullimore Jr.: \"Orthopedic Outfitters has built a reputation for excellent customer service and is recognized as a top dealer in the state of California.  They are an ideal partner to distribute our products in Northern California.  With this agreement, we continue to execute on one of the core pillars of our organic growth strategy &ndash; strengthening our domestic distribution.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321427\" data-linked=\"Dynatronics announces distribution agreement with Orthopedic Outfitters; shares +5%\" data-tweet=\"$DYNT - Dynatronics announces distribution agreement with Orthopedic Outfitters; shares +5% https://seekingalpha.com/news/3321427-dynatronics-announces-distribution-agreement-orthopedic-outfitters-sharesplus-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3321427-dynatronics-announces-distribution-agreement-orthopedic-outfitters-sharesplus-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321425\" data-ts=\"1515163582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSMT\" target=\"_blank\">PSMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321425-pricesmart-updates-on-dec-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PriceSmart updates on Dec. sales</a></h4><ul>     <li>PriceSmart (<a href='https://seekingalpha.com/symbol/PSMT' title='PriceSmart, Inc.'>PSMT</a> <font color='red'>-6.8%</font>) reports sales increased 4.9% in December to $344.2M.</li><li>Comparable warehouse sales were up 6.4% during the month.</li>     <li>The company had 40 warehouse clubs in operation at the end of December, compared to 39 warehouse clubs a year ago.</li>          <li>Shares of PriceSmart are sharply lower on the day after FQ1 results fell short of estimates.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17038952-pricesmart-announces-december-2017-sales\" target=\"_blank\">Press Release</a></li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3321292-net-income-falls-pricesmart\" target=\"_blank\">Net income falls at PriceSmart</a> (Jan. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321425\" data-linked=\"PriceSmart updates on Dec. sales\" data-tweet=\"$PSMT - PriceSmart updates on Dec. sales https://seekingalpha.com/news/3321425-pricesmart-updates-on-dec-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3321425-pricesmart-updates-on-dec-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321423\" data-ts=\"1515163461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIN\" target=\"_blank\">HAIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321423-no-buyer-for-hain-nypost-shares-down-nearly-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No buyer for Hain - NYPost; shares down nearly 2%</a></h4><ul><li>The company has been unable to find a buyer despite being informally on the block for about a year, <a href=\"https://nypost.com/2018/01/04/hain-celestials-brand-overload-the-reason-for-grim-sale-prospects/\" target=\"_blank\">according to the report</a>.</li><li>Founder and CEO Irwin Simon built Hain (<a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='red'>-1.9%</font>) with the intention of ultimately selling, but sources say the large number of brands is scaring off buyers.</li><li>Next up, therefore, may be some divestitures, in particular the chicken and turkey division.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321423\" data-linked=\"No buyer for Hain - NYPost; shares down nearly 2%\" data-tweet=\"$HAIN - No buyer for Hain - NYPost; shares down nearly 2% https://seekingalpha.com/news/3321423-no-buyer-for-hain-nypost-shares-down-nearly-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3321423-no-buyer-for-hain-nypost-shares-down-nearly-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321422\" data-ts=\"1515163333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WING\" target=\"_blank\">WING</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321422-wingstop-slips-after-wedbush-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wingstop slips after Wedbush warning</a></h4><ul> <li>Wingstop (<a href='https://seekingalpha.com/symbol/WING' title='Wingstop, Inc.'>WING</a> <font color='red'>-2.2%</font>) swings lower after Wedbush Securities takes a cautious view on the restaurant stock after the recent rally in share price</li> <li>Analyst Nick Setyan warns that Wingstop's Q4 comparable sales were below estimates (+4% vs. +5% consensus) and thinks the benefit from 2018 advertising may be below expectations.</li> <li>The selling pressure today on Wingstop took shares back below $40.</li><li>Sources: Bloomberg, Nasdaq.com</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321422\" data-linked=\"Wingstop slips after Wedbush warning\" data-tweet=\"$WING - Wingstop slips after Wedbush warning https://seekingalpha.com/news/3321422-wingstop-slips-after-wedbush-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3321422-wingstop-slips-after-wedbush-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321420\" data-ts=\"1515162504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321420-pernix-shakes-up-commercial-business-cuts-22-of-workforce-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pernix shakes up commercial business, cuts 22% of workforce; shares up 3% premarket</a></h4><ul><li>Thinly traded nano cap Pernix Therapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a>) <a href=\"https://seekingalpha.com/pr/17039042-pernix-announces-reorganization-sales-force-focus-zohydro-er-beadtek-silenor\" target=\"_blank\">announces </a>a reorganization of its commercial operations aimed at sharpening its focus on Zohydro ER (hydrocodone bitartrate) and Silenor (doxepin).</li><li>22% of its full-time workforce will be axed and the sales organization will be realigned into 74 territories.</li><li>Management expects the initiative to save $7M - 8M in annual operating expenses. It will record a $1M charge this quarter for related costs.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321420\" data-linked=\"Pernix shakes up commercial business, cuts 22% of workforce; shares up 3% premarket\" data-tweet=\"$PTX $PTX-OLD - Pernix shakes up commercial business, cuts 22% of workforce; shares up 3% premarket https://seekingalpha.com/news/3321420-pernix-shakes-up-commercial-business-cuts-22-of-workforce-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3321420-pernix-shakes-up-commercial-business-cuts-22-of-workforce-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321419\" data-ts=\"1515162412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBCC\" target=\"_blank\">LBCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321419-long-blockchain-in-deal-for-1k-mining-machines-offering-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long Blockchain in deal for 1K mining machines, offering shares</a></h4><ul><li>The company formerly known as Long Island Iced Tea (LTEA) today begins trading under a new symbol: <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a>.</li><li>Alongside <a href=\"https://seekingalpha.com/pr/17039108-long-blockchain-corp-enters-agreement-acquire-1000-bitcoin-mining-machines-manufactured\" target=\"_blank\">is an agreement to buy</a> 1K Antminer S9 mining rigs and 1K APW3++ PSUs from Bitmain. The equipment is set to be shipped this month to a data center in the Nordic region.</li><li>The company is also <a href=\"https://seekingalpha.com/pr/17039058-long-blockchain-corp-announces-public-offering-common-stock\" target=\"_blank\">offering 1.6M shares</a> through Alexander Capital.</li><li>Shares are<font color='red'> down 8.45%</font>&nbsp;premarket to $5.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321419\" data-linked=\"Long Blockchain in deal for 1K mining machines, offering shares\" data-tweet=\"$LBCC - Long Blockchain in deal for 1K mining machines, offering shares https://seekingalpha.com/news/3321419-long-blockchain-in-deal-for-1k-mining-machines-offering-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3321419-long-blockchain-in-deal-for-1k-mining-machines-offering-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321418\" data-ts=\"1515162397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321418-fitbitplus-2_5-roth-initiates-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit +2.5% as Roth initiates at Buy</a></h4><ul>   <li>Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) is <font color='green'>up 2.5%</font> premarket after a start at Buy by Roth Capital, which sees a pioneering company in fitness tracking that has \"legitimate\" digital therapeutic aspirations.</li>    <li>Roth set the company's price target at $10, implying 67% upside.</li>    <li>Shares have declined 59.5% over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321418\" data-linked=\"Fitbit +2.5% as Roth initiates at Buy\" data-tweet=\"$FIT - Fitbit +2.5% as Roth initiates at Buy https://seekingalpha.com/news/3321418-fitbitplus-2_5-roth-initiates-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3321418-fitbitplus-2_5-roth-initiates-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321416\" data-ts=\"1515162112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321416-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a> <font color='green'>+63%</font>&nbsp;on ad terminal <a href=\"https://seekingalpha.com/news/3321358-china-information-technology-plus-82-percent-ad-terminal-sale\" target=\"_blank\">sale</a>.</li><li><a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+33%</font>.</li><li><a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+16%</font>.</li><li><a href='https://seekingalpha.com/symbol/CFMS' title='ConforMIS'>CFMS</a> <font color='green'>+14%</font>.</li><li><a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='green'>+13%</font>.</li><li><a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+12%</font>.</li><li><a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a> <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a> <font color='green'>+10%</font>&nbsp;on clinical progress and <a href=\"https://seekingalpha.com/news/3321383-zafgen-reports-clinical-progress-updates-outlook-2018\" target=\"_blank\">updates outlook</a> for 2018.</li><li><a href='https://seekingalpha.com/symbol/CGA' title='China Green Agriculture, Inc.'>CGA</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17039056-hveminus-3dgfx-graphic-intense-vdi-workloads-drives-multiple-wins-kick-2018\" target=\"_blank\">announcement</a> that HVE ConneXions has recently secured purchase orders with a number of customers.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+8%</font>&nbsp;as no coins are being&nbsp;<a href=\"https://seekingalpha.com/news/3321380-coinbase-coins-added\" target=\"_blank\">added</a>&nbsp;to coinbase.</li><li><a href='https://seekingalpha.com/symbol/WBAI' title='500.com Limited'>WBAI</a> <font color='green'>+8%</font>&nbsp;on positive analyst <a href=\"https://seekingalpha.com/news/3321408-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li><li><a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='green'>+6%</font>&nbsp;as <a href=\"https://seekingalpha.com/news/3316469-chinas-21vianet-group-minus-4_4-percent-losses-widen-impairments\" target=\"_blank\">losses</a> widen on impairments.</li><li><a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a> <font color='green'>+6%</font>&nbsp;as no coins are being <a href=\"https://seekingalpha.com/news/3321380-coinbase-coins-added\" target=\"_blank\">added</a> to coinbase.</li><li>NQ <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321416\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CNIT-OLD $CCIH $CCCR-OLD - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3321416-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3321416-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321413\" data-ts=\"1515161695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321413-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a>&nbsp;<font color='red'>-79%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321351-ohr-pharmas-mako-study-fails\" target=\"_blank\">failure</a> of MAKO study.</li><li><a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321301-francescas-lowers-guidance\" target=\"_blank\">lowering</a> guidance.</li><li><a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321308-regenxbio-updates-pipeline-progress-provides-2018-guidance-shares-16-percent-hours\" target=\"_blank\">providing</a> clinical updates and 2018 guidance.</li><li><a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321379-barnes-and-noble-updates-holiday-sales\" target=\"_blank\">reporting</a> holiday sales.</li><li><a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>&nbsp;<font color='red'>-6%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3321367-roku-suffers-2nd-downgrade-2-days\" target=\"_blank\">downgraded</a> by Citi.</li><li><a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321384-kala-pharmas-lead-candidate-shows-mixed-results-two-late-state-dry-eye-disease-studies-shares\" target=\"_blank\">announcing</a> topline results for two Phase 3 Trials, STRIDE 1 and STRIDE 2 of KPI-121 0.25% in dry eye disease.</li><li><a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321413\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$NBSE $FRAN $RGNX - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3321413-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3321413-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321412\" data-ts=\"1515161547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321412-strong-canadian-jobs-report-sends-loonie-flying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong Canadian jobs report sends loonie flying</a></h4><ul><li><a href=\"http://www.statcan.gc.ca/daily-quotidien/180105/dq180105a-eng.htm?HPA=1\" target=\"_blank\">Canada added 78.6K jobs</a> in December, blowing past estimates for just 2K.</li><li>The unemployment rate fell to 5.7%, the lowest since the data series started in 1976. Estimates were for 6%.</li><li>For the year, employment was up 423K jobs.</li><li>The loonie has jumped about 140 pips vs. the dollar on the news, now buying $0.8085, the most since late September. <a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a><font color='green'> +1%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3321397-dec-jobs-come-light-148k\" target=\"_blank\">Dec. jobs come in light at 148K</a> (Jan. 5)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321412\" data-linked=\"Strong Canadian jobs report sends loonie flying\" data-tweet=\"$FXC $EWC $CNDA - Strong Canadian jobs report sends loonie flying https://seekingalpha.com/news/3321412-strong-canadian-jobs-report-sends-loonie-flying?source=tweet\" data-url=\"https://seekingalpha.com/news/3321412-strong-canadian-jobs-report-sends-loonie-flying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321411\" data-ts=\"1515160963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORE\" target=\"_blank\">CORE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321411-core-mark-lowers-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Core-Mark lowers profit guidance</a></h4><ul> <li>Core-Mark Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CORE' title='Core-Mark Holding Company, Inc.'>CORE</a>) issues&nbsp;preliminary financial results for 2017.</li><li>The company expects to report full-year sales of $15.7B and adjusted EBITDA of $136M to $141M . EPS guidance is lowered to $0.94 to $1.01 from $1.20 to $1.24 and compared to $1.19 consensus.</li><li>CEO update: \"Unfortunately, many of our customers did not see an overall retail sales lift, particularly in California, driven primarily by cigarette carton volume declines. We do not expect to meet our previous expectations for Adjusted EBITDA, primarily due to the performance of our two recovering divisions and not realizing our operational cost reduction initiatives at the pace we expected.\"</li><li>CORE  <font color='red'>-1.02%</font> premarket to  $31.09.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17039041-core-mark-updates-2017-outlook-provides-2018-guidance\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321411\" data-linked=\"Core-Mark lowers profit guidance\" data-tweet=\"$CORE - Core-Mark lowers profit guidance https://seekingalpha.com/news/3321411-core-mark-lowers-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3321411-core-mark-lowers-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321403\" data-ts=\"1515160060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321403-kroger-perky-after-jefferies-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger perky after Jefferies lift</a></h4><ul> <li>Shares of Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>) are active  after Jefferies <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Jefferies+Upgrades+Kroger+%28KR%29+to+Buy/13658515.html\" target=\"_blank\">upgrades</a> the grocery store operator to Buy from Hold.</li> <li>Kroger is <font color='green'>up 1.22%</font> in the premarket session to $27.31 vs. a 52-week trading range of $19.69 to $34.99. The stock still hasn't fully recovered from the level it traded at right before the bombshell Whole Foods acquisition by Amazon last June.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321403\" data-linked=\"Kroger perky after Jefferies lift\" data-tweet=\"$KR - Kroger perky after Jefferies lift https://seekingalpha.com/news/3321403-kroger-perky-after-jefferies-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3321403-kroger-perky-after-jefferies-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321400\" data-ts=\"1515159373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLLI\" target=\"_blank\">OLLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321400-ollie-s-bargain-outlet-holdings-updates-on-holiday-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ollie\u2019s Bargain Outlet Holdings updates on holiday sales</a></h4><ul>     <li>Ollie&rsquo;s Bargain Outlet Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings'>OLLI</a>) reports that holiday sales over a&nbsp;nine-week period increased 19.4%.</li>     <li>Comparable store sales were up 3.9% during the key two months.</li>     <li>Ollie's issues new guidance for the full year after factoring in the holiday period activity. The retailer expects to report sales of ~$1.070B vs. $1.06B consensus, comparable store sales growth of approximately 2.8% and adjusted net income per share of approximately $1.23.</li>     <li>The company plans to report full Q4 results on February 3.</li>     <li>OLLI  <font color='green'>+1.15%</font> premarket to  $52.70.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17039015-ollie-s-bargain-outlet-holdings-inc-reports-strong-holiday-sales-raises-full-year-outlook\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321400\" data-linked=\"Ollie\u2019s Bargain Outlet Holdings updates on holiday sales\" data-tweet=\"$OLLI - Ollie\u2019s Bargain Outlet Holdings updates on holiday sales https://seekingalpha.com/news/3321400-ollie-s-bargain-outlet-holdings-updates-on-holiday-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3321400-ollie-s-bargain-outlet-holdings-updates-on-holiday-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321398\" data-ts=\"1515159117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321398-xilinxplus-3_4-after-goldman-sachs-upgrade-price-target-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xilinx +3.4% after Goldman Sachs upgrade, price target increase</a></h4><ul><li>        Goldman Sachs <a href=\"https://www.cnbc.com/2018/01/05/stocks-making-the-biggest-moves-premarket-shld-stz-sonc-aapl-tgt-more.html\" target=\"_blank\">upgrades</a> Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) from Neutral to Buy and raises the price target from $72 to $78, which is 7% above the current share price. &nbsp;</li><li>           Firm cites signs of improving demand for the company&rsquo;s communications business. </li><li> Xilinx shares are&nbsp;<font color='green'>up 3.4%</font>&nbsp;premarket to $72.85.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3321323-xilinx-names-peng-new-ceo-gavrielov-retires\" target=\"_blank\">Xilinx names Peng new CEO as Gavrielov retires</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321398\" data-linked=\"Xilinx +3.4% after Goldman Sachs upgrade, price target increase\" data-tweet=\"$XLNX - Xilinx +3.4% after Goldman Sachs upgrade, price target increase https://seekingalpha.com/news/3321398-xilinxplus-3_4-after-goldman-sachs-upgrade-price-target-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3321398-xilinxplus-3_4-after-goldman-sachs-upgrade-price-target-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321392\" data-ts=\"1515158774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDRA\" target=\"_blank\">IDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321392-idera-pharmaceuticals-provides-2018-update-and-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idera Pharmaceuticals provides 2018 update and outlook</a></h4><ul><li>Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) <a href=\"https://seekingalpha.com/pr/17038908-idera-pharmaceuticals-provides-2018-update-outlook\" target=\"_blank\">provides</a> an update on its clinical development programs and 2018 outlook.</li>     <li>Following are the updates on clinical development programs:</li>  <li>ILLUMINATE 204 &ndash; Phase 1/2 Trial of IMO-2125 in Combination with Ipilimumab or Pembrolizumab in patients with PD-1 refractory metastatic melanoma: Enrolled 21 patients at 8mg (RP2D) dose with ipilimumab.</li><li>In pembrolizumab combination arm of the trial, phase 1 dose escalation continues into the last dosing cohort (32mg).</li>  <li>ILLUMINATE 101 &ndash; Phase 1b Trial of Intratumoral IMO-2125 Monotherapy in patients with refractory solid tumors: Completed enrollment of 11 patients in first cohort with 8mg dose of IMO-2125.</li><li>Advanced to enrollment of second cohort (9 patients treated with 16mg dose of IMO-2125).</li><li>ILLUMINATE 301 &ndash; Phase 3 Trial of IMO-2125 in Combination with Ipilimumab in patients with PD-1 refractory metastatic melanoma:&nbsp;Trial planned in Q1 enrolling 300 patients with overall response rate and overall survival as trial endpoints. FDA granted Fast Track Designation for IMO-2125 in combination with ipilimumab in Q4 2017.</li>          <li>PIONEER &ndash; Phase 2 Trial data of IMO-8400 in adult patients with Dermatomyositis is expected in Q2.</li>      <li>IDRA &ndash; 008 Development Activities: Pre-clinical study in Cyno-model comparing IDRA-008 to Volanesorsen is expected to readout during Q1.</li>    <li>Corporate Updates: On January 4, reverse stock split of not less than 1-for-4 and not more than 1-for-8 approved.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3321392\" data-linked=\"Idera Pharmaceuticals provides 2018 update and outlook\" data-tweet=\"$IDRA - Idera Pharmaceuticals provides 2018 update and outlook https://seekingalpha.com/news/3321392-idera-pharmaceuticals-provides-2018-update-and-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3321392-idera-pharmaceuticals-provides-2018-update-and-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321390\" data-ts=\"1515158449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCP\" target=\"_blank\">HCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321390-hcpminus-2-after-loan-goes-bad\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCP -2% after loan goes bad</a></h4><ul><li>The company expects material impairment (more than $20M) from a mezzanine loan to Tandem Health. Tandem does remain current on its senior loan.</li><li><a href='https://seekingalpha.com/symbol/HCP' title='HCP, Inc.'>HCP</a>&nbsp;<font color='red'>-2.1%</font>&nbsp;premarket</li><li>Source: <a href=\"https://seekingalpha.com/filing/3823594\" target=\"_blank\">SEC Form 8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321390\" data-linked=\"HCP -2% after loan goes bad\" data-tweet=\"$HCP $PEAK - HCP -2% after loan goes bad https://seekingalpha.com/news/3321390-hcpminus-2-after-loan-goes-bad?source=tweet\" data-url=\"https://seekingalpha.com/news/3321390-hcpminus-2-after-loan-goes-bad\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321389\" data-ts=\"1515158224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321389-amazon-in-talks-for-premier-league-streaming-rights\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon in talks for Premier League streaming rights</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) is in talks to stream Premier League soccer matches, according to <a href=\"http://www.telegraph.co.uk/football/2018/01/04/amazon-holds-talks-premier-league-uk-tv-rights/\" target=\"_blank\">The Daily Telegraph</a> sources. The rights would cover three years from 2019 to 2022.</li><li>               The U.K. rights for the League go up for auction next month. British telecoms Sky and BT won the last auction, which brought in $6.9B.&nbsp;</li><li>               Amazon shelled out $50M last year for the rights to live-stream NFL games and &pound;80M for the UK rights to the US Open and ATP World Tour.&nbsp;</li><li>Amazon shares are&nbsp;<font color='green'>up 0.3%</font>&nbsp;premarket.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321243-alexa-can-now-control-microwaves-ovens-amazon-invests-smart-oven-startup\" target=\"_blank\">Alexa can now control microwaves, ovens; Amazon invests in smart oven startup</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321389\" data-linked=\"Amazon in talks for Premier League streaming rights\" data-tweet=\"$AMZN - Amazon in talks for Premier League streaming rights https://seekingalpha.com/news/3321389-amazon-in-talks-for-premier-league-streaming-rights?source=tweet\" data-url=\"https://seekingalpha.com/news/3321389-amazon-in-talks-for-premier-league-streaming-rights\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321384\" data-ts=\"1515158011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KALA\" target=\"_blank\">KALA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321384-kala-pharmas-lead-candidate-shows-mixed-results-in-two-late-state-dry-eye-disease-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kala Pharma&#39;s lead candidate shows mixed results in two late-state dry eye disease studies; shares down 16% premarket</a></h4><ul><li>Thinly traded micro cap Kala Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a>) slumps&nbsp;<font color='red'>16%</font>&nbsp;premarket on average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17038882-kala-pharmaceuticals-announces-topline-results-two-phase-3-trials-stride-1-stride-2-kpiminus\" target=\"_blank\">announcement </a>of results from two Phase 3 clinical trials, STRIDE 1 and STRIDE 2, evaluating lead candidate KPI-121 (loteprednol etabonate) in patients with dry eye disease.</li><li>STRIDE 1 achieved its primary sign endpoint of the change in conjunctival hyperemia from baseline to day 15 (p&lt;0.0001) and the primary symptom endpoint of the severity of ocular discomfort from baseline to day 15 (p&lt;0.0001), but missed a secondary endpoint, the change in inferior corneal staining from baseline to day 15 (p=0.1128).</li><li>STRIDE 2 met the primary sign endpoint, but missed the primary symptom endpoint (p=0.1298) and missed the secondary ocular discomfort endpoint (p=0.0799).</li><li>On the safety front, the most common adverse event in STRIDE 1 was instillation site pain (6.1% in both treatment and placebo groups). The only other adverse event occurring in more than 1% of patients was eye irritation (1.1% in the KPI-121 cohort versus 1.5% for placebo).</li><li>In STRIDE 2, the incidence of instillation pain was 5.7% in the treatment group compared to 4.4% for placebo. Blurred vision was reported in 0.2% of the patients in the KPI-121 group versus 1.3% for placebo. Elevations in intraocular pressure &#40;IOP&#41;, a known side effect from topical corticosteroid use, were similar between the two groups. 1.1% of the KPI-121 cohort experienced an increase in IOP of at least 5 mmHg which resulted in an IOP of at least 21 mmHg (normal range: 12 - 22 mmHg).</li></ul><div class=\"tiny-share-widget\" data-id=\"3321384\" data-linked=\"Kala Pharma&#39;s lead candidate shows mixed results in two late-state dry eye disease studies; shares down 16% premarket\" data-tweet=\"$KALA - Kala Pharma&#39;s lead candidate shows mixed results in two late-state dry eye disease studies; shares down 16% premarket https://seekingalpha.com/news/3321384-kala-pharmas-lead-candidate-shows-mixed-results-in-two-late-state-dry-eye-disease-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3321384-kala-pharmas-lead-candidate-shows-mixed-results-in-two-late-state-dry-eye-disease-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321383\" data-ts=\"1515157052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZFGN\" target=\"_blank\">ZFGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321383-zafgen-reports-clinical-progress-and-updates-outlook-for-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zafgen reports clinical progress and updates outlook for 2018</a></h4><ul><li>Zafgen (NASDAQ:<a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>) <a href=\"https://seekingalpha.com/pr/17038903-zafgen-reports-strong-clinical-progress-updates-outlook-2018\" target=\"_blank\">announces</a> strong clinical progress with its lead ZGN-1061 program currently in development for patients with complex type 2 diabetes.</li>    <li>Key updates and milestones in 2018 across each program include:</li>  <li><a href=\"http://www.zafgen.com/zafgen/our-approach/zgn-1061\" target=\"_blank\">ZGN-1061</a> for Type 2 Diabetes: Completed enrollment of 137 patients versus 120 planned. The Phase 2 trial is designed to evaluate safety, tolerability and glucose-lowering efficacy in diabetes patients who are also obese. Topline data are expected mid-year 2018.</li>    <li><a href=\"http://www.zafgen.com/zafgen/our-approach/zgn-1061\" target=\"_blank\">ZGN-1258</a> for <a href=\"https://en.wikipedia.org/wiki/Prader%E2%80%93Willi_syndrome\" target=\"_blank\">Prader-Willi Syndrome</a> and Additional Rare Disorders: Zafgen is beginning investigational new drug application-enabling work in Q1 and will commence Phase 1 clinical development by end of 2018.</li><li>Financial: Zafgen entered into a $20M venture debt financing agreement with Silicon Valley Bank on December 29, 2017.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume.</li>        </ul><div class=\"tiny-share-widget\" data-id=\"3321383\" data-linked=\"Zafgen reports clinical progress and updates outlook for 2018\" data-tweet=\"$ZFGN - Zafgen reports clinical progress and updates outlook for 2018 https://seekingalpha.com/news/3321383-zafgen-reports-clinical-progress-and-updates-outlook-for-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3321383-zafgen-reports-clinical-progress-and-updates-outlook-for-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321381\" data-ts=\"1515156222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321381-axios-aspen-institute-launching-cybersecurity-initiative-ibm-politicians-academics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axios: Aspen Institute launching cybersecurity initiative with IBM, politicians, academics</a></h4><ul><li>Axios <a href=\"https://www.axios.com/aspen-cyber-strategy-group-ibm-launch-2522540326.html\" target=\"_blank\">reports</a> that&nbsp; the Aspen Institute is launching a cybersecurity initiative to &ldquo;address a wide range of cybersecurity vulnerabilities on a national scale.&rdquo; The chairs of the effort are IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) CEO Ginni Rometty, Lisa Monaco, Homeland Security Adviser under the Obama administration, and Congressman Will Hurd (R-TX.).</li><li>The Aspen Cyber Strategy Group wants to assemble 35 members representing academia, government, and the private sector to meet several times this year, form sub-groups, and issue reports outlining actions that can improve the cybersecurity landscape.</li><li>Members include Gen. Keith Alexander, Duke Energy CEO Lynn Good, and Booz Allen Hamilton VP Brad Maiorino.</li><li>IBM shares are&nbsp;<font color='green'>up 0.6%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320858-ibm-called-attractive-large-cap-value-top-analyst-shares-plus-1_4-percent\" target=\"_blank\">IBM called \"attractive large-cap value\" by top analyst; shares +1.4%</a> (Jan. 3)</li><li>Correction: A previous version of this article named IBM, not Aspen Institute, as the initiative leader.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321381\" data-linked=\"Axios: Aspen Institute launching cybersecurity initiative with IBM, politicians, academics\" data-tweet=\"$IBM - Axios: Aspen Institute launching cybersecurity initiative with IBM, politicians, academics https://seekingalpha.com/news/3321381-axios-aspen-institute-launching-cybersecurity-initiative-ibm-politicians-academics?source=tweet\" data-url=\"https://seekingalpha.com/news/3321381-axios-aspen-institute-launching-cybersecurity-initiative-ibm-politicians-academics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321380\" data-ts=\"1515155884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COINB\" target=\"_blank\">COINB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321380-coinbase-no-coins-being-added\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coinbase: No coins being added</a></h4><ul><li>Among the reasons cited for Ripple's scorching run (at its high yesterday, up 15-fold in a month) was the rumor that Coinbase (<a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>) as soon as next week was going to add the coin to its small list of tradable assets (joining Bitcoin, Ether, Litecoin, and Bitcoin Cash).</li><li>In a blog post yesterday, <a href=\"https://blog.coinbase.com/our-process-for-adding-new-assets-f97b7ba65bea\" target=\"_blank\">Coinbase said no decision </a>has been made to add any additional assets. The statement may have been responsible for the quick decline in Ripple from about $3.30 to $2.50 (it's currently at $2.78).</li><li>It also may have helped return buying focus to Bitcoin - previously mired in the $13K-$15K range, the coin broke out to above $16K earlier this morning (currently at $15.9K). Money is also moving into Ether, which earlier broke through $1K for the first time ever (currently at $989).</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/CRCW' title='The Crypto Company'>OTC:CRCW</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321380\" data-linked=\"Coinbase: No coins being added\" data-tweet=\"$COINB $COINB $GBTC - Coinbase: No coins being added https://seekingalpha.com/news/3321380-coinbase-no-coins-being-added?source=tweet\" data-url=\"https://seekingalpha.com/news/3321380-coinbase-no-coins-being-added\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321373\" data-ts=\"1515155081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321373-bofaml-upgrades-cisco-and-f5-networks-to-new-street-high-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML upgrades Cisco and F5 Networks to new Street-high targets</a></h4><ul><li>        Bank of America Merrill Lynch upgrades Cisco (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) and F5 Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) from Neutral to Buy.</li><li>               Analyst Tal Liani says Cisco is in the early stages of a positive software transition and shares will re-rate closer to its peers.&nbsp;</li><li>               Firm ups Cisco&rsquo;s price target from $37 to the Street-high $46.&nbsp;</li><li>               F5 also gets a price target increase from $130 to the Street-high $157 on new product offerings and pricing that could &ldquo;reposition the company to benefit from industry transitions, rather than be threatened by them.&rdquo;&nbsp;</li><li>               Source: Bloomberg First Word &nbsp;&nbsp;</li><li>               Cisco shares are&nbsp;<font color='green'>up 2%</font>&nbsp;premarket.&nbsp;</li><li>               F5 shares are&nbsp;<font color='green'>up 1%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321373\" data-linked=\"BofAML upgrades Cisco and F5 Networks to new Street-high targets\" data-tweet=\"$CSCO $CSCO $FFIV - BofAML upgrades Cisco and F5 Networks to new Street-high targets https://seekingalpha.com/news/3321373-bofaml-upgrades-cisco-and-f5-networks-to-new-street-high-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3321373-bofaml-upgrades-cisco-and-f5-networks-to-new-street-high-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321372\" data-ts=\"1515155017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FC\" target=\"_blank\">FC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321372-franklin-covey-up-nearly-10-after-big-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Franklin Covey up nearly 10% after big quarter</a></h4><ul><li>2016's launch of the All Access Pass begins to pay dividends, with FQ1 sales up 20% Y/Y to $47.9M, and gross margin up 500 basis points to 68.6%.</li><li>Adjusted EBITDA of $600K compares to a loss of $2.8M in FQ1 a year ago.</li><li>The company reaffirms its full-year fiscal 2018 outlook for adjusted EBITDA of $10M-$15M.</li><li><a href='https://seekingalpha.com/symbol/FC' title='Franklin Covey Company'>FC</a>&nbsp;<font color='green'>+9.8%</font>&nbsp;premarket</li><li>See also: <a href=\"https://seekingalpha.com/article/3964129-overlooked-transformation-makes-franklin-covey-compelling-buy\" target=\"_blank\">Overlooked Transformation Makes Franklin Covey A Compelling Buy</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3321302-franklin-covey-beats-0_16-beats-revenue\" target=\"_blank\">Franklin Covey beats by $0.16, beats on revenue</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321372\" data-linked=\"Franklin Covey up nearly 10% after big quarter\" data-tweet=\"$FC - Franklin Covey up nearly 10% after big quarter https://seekingalpha.com/news/3321372-franklin-covey-up-nearly-10-after-big-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3321372-franklin-covey-up-nearly-10-after-big-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321369\" data-ts=\"1515154398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321369-tech-giants-see-little-performance-impact-from-intel-chip-issues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech giants see little performance impact from Intel chip issues</a></h4><ul><li>        The Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) chip issues have only <a href=\"https://www.reuters.com/article/us-cyber-microchips/apple-researchers-eye-patches-to-solve-intel-chip-flaws-idUSKBN1EU12H?feedType=RSS&amp;feedName=topNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtopNews+%28News+%2F+US+%2F+Top+News%29\" target=\"_blank\">slowed computers slightly</a>, according to impacted tech giants, and security researchers have backed off the need for hardware replacements.</li><li>               Intel <a href=\"https://newsroom.intel.com/news-releases/industry-testing-shows-recently-released-security-updates-not-impacting-performance-real-world-deployments/\" target=\"_blank\">says</a> Apple, Amazon, Google, and Microsoft all reported little to no performance impact from the required security patches.</li><li>               Microsoft and Google separately say they expect few performance issues for cloud computing customers. Apple also independently confirmed that its tests showed no significant processing speed impact from the patches.&nbsp;</li><li>               Carnegie Mellon&rsquo;s cybersecurity project CERT withdraws recommending CPU replacement for an affected system. CERT now says that &ldquo;operating system and some application updates mitigate these attacks.&rdquo; &nbsp;&nbsp;</li><li>               Intel shares are&nbsp;<font color='green'>up 0.2%</font>&nbsp;premarket.&nbsp;</li><li>               Shares of competitor AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) are&nbsp;<font color='green'>up 1.7%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321179-tech-giants-scurry-patch-chip-flaws-intel-minus-2_6-percent\" target=\"_blank\">Tech giants scurry to patch chip flaws; Intel -2.6%</a> (Jan. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321278-intel-updates-flawed-chips-barclays-says-co-take-financial-hit\" target=\"_blank\">Intel updates flawed chips; Barclays says co. won't take financial hit</a> (Jan. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321328-apple-confirms-devices-affected-processor-exploits\" target=\"_blank\">Apple confirms all its devices affected by processor exploits</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321369\" data-linked=\"Tech giants see little performance impact from Intel chip issues\" data-tweet=\"$INTC $INTC $AMD - Tech giants see little performance impact from Intel chip issues https://seekingalpha.com/news/3321369-tech-giants-see-little-performance-impact-from-intel-chip-issues?source=tweet\" data-url=\"https://seekingalpha.com/news/3321369-tech-giants-see-little-performance-impact-from-intel-chip-issues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321367\" data-ts=\"1515154281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321367-roku-suffers-2nd-downgrade-in-2-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku suffers 2nd downgrade in 2 days</a></h4><ul><li>The high-flyer<font color='red'> fell 7.6%</font>&nbsp;yesterday after Morgan Stanley downgraded to Underweight, and is&nbsp;<font color='red'>lower by 1.45%</font>&nbsp;premarket as Citi's Mark May cuts to Sell.</li><li>May is \"uncertain\" about the reasons for the more than tripling in the stock price, but takes note of the small float and limited number of over-the-top plays for investors.</li><li>Roku's (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) 21x multiple compares to peers at 5.2x and Netflix at 18x. While peers are profitable, Roku will probably have to wait until 2019 to be so.</li><li>Source: Bloomberg's Courtney Dentch</li></ul><div class=\"tiny-share-widget\" data-id=\"3321367\" data-linked=\"Roku suffers 2nd downgrade in 2 days\" data-tweet=\"$ROKU - Roku suffers 2nd downgrade in 2 days https://seekingalpha.com/news/3321367-roku-suffers-2nd-downgrade-in-2-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3321367-roku-suffers-2nd-downgrade-in-2-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321362\" data-ts=\"1515153824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TKPHF\" target=\"_blank\">TKPHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321362-takeda-to-acquire-tigenix-for-520m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeda to acquire TiGenix for \u20ac520M</a></h4><ul><li>Takeda Pharmaceutical Company (<a href='https://seekingalpha.com/symbol/TKPHF' title='Takeda Pharmaceutical Co., Ltd.'>OTCPK:TKPHF</a>)(TKPYY) has <a href=\"https://seekingalpha.com/pr/17038821-takeda-announces-intention-acquire-tigenix\" target=\"_blank\">agreed to acquire</a> TiGenix NV (NASDAQ:<a href='https://seekingalpha.com/symbol/TIG' title='TiGenix NV  &#40;ADS&#41;'>TIG</a>) for ~&euro;520M in cash or &euro;1.78/ordinary share (&euro;35.60/ADS).</li><li>The Belgian biotech's lead candidate is adipose-derived mesenchymal stem cell product Cx601 for the treatment of complex perianal fistulas in patients with non-active/mildly active Crohn's disease. It should be approved in Europe in the coming weeks and will be marketed under the brand name Alofisel.</li><li>Takeda owned ex-U.S. rights to Cx601 under a July 2016 agreement.</li><li>TiGenix closed yesterday at $23.68/ADS (&euro;28.65).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3318542-european-advisory-group-backs-tigenixs-alofisel-complex-perianal-fistulas-crohns-patients\" target=\"_blank\">European advisory group backs TiGenix's Alofisel for complex perianal fistulas in Crohn's patients</a> (Dec. 15, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3191648-takeda-nabs-ex-u-s-rights-investigational-stem-cell-treatment-crohns-related-fistulas\" target=\"_blank\">Takeda nabs ex-U.S. rights to investigational stem cell treatment for Crohn's-related fistulas</a> (July 5, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321362\" data-linked=\"Takeda to acquire TiGenix for \u20ac520M\" data-tweet=\"$TKPHF $TKPHF $TAK - Takeda to acquire TiGenix for \u20ac520M https://seekingalpha.com/news/3321362-takeda-to-acquire-tigenix-for-520m?source=tweet\" data-url=\"https://seekingalpha.com/news/3321362-takeda-to-acquire-tigenix-for-520m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321365\" data-ts=\"1515153741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYD\" target=\"_blank\">BYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321365-baml-positive-on-boyd-gaming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML positive on Boyd Gaming</a></h4><ul> <li>Bank of America Merril Lynch upgrades Boyd Gaming (NYSE:<a href='https://seekingalpha.com/symbol/BYD' title='Boyd Gaming Corporation'>BYD</a>) to a Buy rating after having the casino stock lined up at Neutral.</li> <li>The re-evaluation on Boyd follows the company's deal to acquire four strategic assets out of the Penn-Pinnacle merger at attractive prices.</li><li>The firm hikes its price target to <a href=\"https://www.marketbeat.com/stocks/NYSE/BYD/\" target=\"_blank\">$42</a> from $36.</li> <li>Shares of Boyd are <font color='green'>up 1.48%</font> in premarket action.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321365\" data-linked=\"BAML positive on Boyd Gaming\" data-tweet=\"$BYD - BAML positive on Boyd Gaming https://seekingalpha.com/news/3321365-baml-positive-on-boyd-gaming?source=tweet\" data-url=\"https://seekingalpha.com/news/3321365-baml-positive-on-boyd-gaming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321361\" data-ts=\"1515153408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALM\" target=\"_blank\">CALM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321361-on-cal-maine-foods-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Cal-Maine Foods&#39; Q2</a></h4><ul><li>Cal-Maine Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a>)&nbsp;reports egg sales rose 4% Y/Y to 263.09M in <a href=\"https://seekingalpha.com/pr/17038862-cal-maine-foods-reports-second-quarter-fiscal-2018-results\" target=\"_blank\">Q2</a>.</li><li>Specialty-egg sales accounted for 32.3% of total revenue, fell 1350 bps Y/Y.</li><li>Average price +36% to $1.321 per dozen.</li><li>The average selling price for specialty eggs fell 5% to $1.903.</li><li>Gross margin rate was 22.8% for the quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321361\" data-linked=\"More on Cal-Maine Foods&#39; Q2\" data-tweet=\"$CALM - More on Cal-Maine Foods&#39; Q2 https://seekingalpha.com/news/3321361-on-cal-maine-foods-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3321361-on-cal-maine-foods-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321358\" data-ts=\"1515153251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNIT-OLD\" target=\"_blank\">CNIT-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321358-china-information-technologyplus-82-on-ad-terminal-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Information Technology +82% on ad terminal sale</a></h4><ul><li>        China Information Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a>) shares are&nbsp;<font color='green'>up 81.7%&nbsp;</font>premarket still gaining from Wednesday&rsquo;s announced sale contract for 5K CNIT cloud-based ad terminals.</li><li>               The contract with ad agency Beijing Taoping IoT Technology Is expected to generate about $1.5M in sales and service revenue.&nbsp;</li><li>               The ad terminals will be installed in offices, residential communities, shopping malls, and outdoor locations in Hebei and Liaoning. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320166-china-information-technology-announces-1m-contract\" target=\"_blank\">China Information Technology announces $1M contract</a> (Dec. 27, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321358\" data-linked=\"China Information Technology +82% on ad terminal sale\" data-tweet=\"$CNIT-OLD - China Information Technology +82% on ad terminal sale https://seekingalpha.com/news/3321358-china-information-technologyplus-82-on-ad-terminal-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3321358-china-information-technologyplus-82-on-ad-terminal-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321354\" data-ts=\"1515151312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321354-greenbrier-reaffirms-fy2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenbrier reaffirms FY2018 guidance</a></h4><ul><li>Greenbrier (NYSE:<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a>) reports Manufacturing revenue fell 1% to $451.49M in <a href=\"https://seekingalpha.com/pr/17038855-greenbrier-reports-first-quarter-results\" target=\"_blank\">Q1</a>.</li><li>Wheels &amp; Parts revenue rose 12% to $78.01M.</li><li>Leasing &amp; Services revenue up 5% to $30.04M.</li><li>Gross margin rate squeezed 440 bps to 16%.</li><li>S&amp;A expense rate +90 bps to 8.5%.</li><li>Operating margin rate dropped 220 bps to 11%.</li><li>New rail car deliveries declined 20% Q/Q to 4,400 units.</li><li>New railcar manufacturing backlog was 26.5K units valued at $2.56B at quarter's end, vs. 28.6K units valued at $2.8B as of Aug. 31.</li><li><b>FY2018 Guidance</b>: Deliveries: 20,000 to 22,000 units; Revenues: $2.4B to $2.6B; Diluted EPS: $4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321354\" data-linked=\"Greenbrier reaffirms FY2018 guidance\" data-tweet=\"$GBX - Greenbrier reaffirms FY2018 guidance https://seekingalpha.com/news/3321354-greenbrier-reaffirms-fy2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3321354-greenbrier-reaffirms-fy2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321351\" data-ts=\"1515150894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHRP\" target=\"_blank\">OHRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321351-ohr-pharmas-mako-study-fails\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ohr Pharma&#39;s MAKO study fails</a></h4><ul> <li>Ohr Pharmaceutical (<a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a>), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline data from the MAKO study which did not meet its primary efficacy endpoint. The MAKO study evaluated the efficacy and safety of topically administered squalamine in combination with monthly Lucentis injections for the treatment of wet age-related macular degeneration (&ldquo;wet-AMD&rdquo;). The primary efficacy endpoint was the mean visual acuity gain at nine months, using a mixed-effects model for repeated measures (\"MMRM\") analysis. Subjects receiving squalamine combination therapy (n=119) achieved a mean gain of 8.33 letters from baseline versus 10.58 letters from baseline with Lucentis monotherapy (n=118).</li>   <li>&ldquo;We are very disappointed with the outcome of the MAKO study,&rdquo; commented Dr. Jason Slakter, chief executive officer of Ohr. &ldquo;Based on these results, we intend to evaluate strategic alternatives to maximize shareholder value.&rdquo;</li><li>Shares of OHRP were down <font color='red'>3.5%</font> in after-hours trading yesterday.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17038854-ohr-pharmaceutical-announces-efficacy-results-mako-study-wet-amd\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321351\" data-linked=\"Ohr Pharma&#39;s MAKO study fails\" data-tweet=\"$OHRP $NBSE - Ohr Pharma&#39;s MAKO study fails https://seekingalpha.com/news/3321351-ohr-pharmas-mako-study-fails?source=tweet\" data-url=\"https://seekingalpha.com/news/3321351-ohr-pharmas-mako-study-fails\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}